Patents by Inventor Marco Marchesan

Marco Marchesan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alogliptin formulation
    Patent number: 10548848
    Abstract: The present invention belongs to the field of pharmaceutical industry and relates to a pharmaceutical composition comprising an intragranulate phase and an extragranulate phase, wherein the pharmaceutically active ingredient (API) 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile or a pharmaceutically acceptable salt thereof, is present in the intragranulate phase, wherein said intragranulate phase is free from microcrystalline cellulose. Further, the present invention relates to a process for preparing the same.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: February 4, 2020
    Assignee: Hexal AG
    Inventors: Thomas Kohr, Christian Wawra, Marco Marchesan
  • Alogliptin Formulation
    Publication number: 20180133160
    Abstract: The present invention belongs to the field of pharmaceutical industry and relates to a pharmaceutical composition comprising an intragranulate phase and an extragranulate phase, wherein the pharmaceutically active ingredient (API) 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile or a pharmaceutically acceptable salt thereof, is present in the intragranulate phase, wherein said intragranulate phase is free from microcrystalline cellulose. Further, the present invention relates to a process for preparing the same.
    Type: Application
    Filed: June 16, 2016
    Publication date: May 17, 2018
    Applicant: Hexal Aktiengesellschaft
    Inventors: Thomas Kohr, Christian Wawra, Marco Marchesan
  • Enteric coating
    Publication number: 20120082721
    Abstract: The present invention refers to a dosage form comprising an enteric coating in a specific amount, and to the use of enteric coating compositions for preparing a dosage form. Furthermore, the present invention also relates to a process for the preparation of a solid oral dosage form.
    Type: Application
    Filed: May 28, 2010
    Publication date: April 5, 2012
    Applicant: H E X A L Aktiengesellschaft
    Inventors: Christian Buessing, Marco Marchesan, Andreas Krekeler